Short Interest in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Expands By 15.8%

NeuroOne Medical Technologies Co. (NASDAQ:NMTC) saw a significant growth in short interest during the month of August. As of August 31st, there was short interest totalling 130,200 shares, a growth of 15.8% from the August 15th total of 112,400 shares. Approximately 0.5% of the shares of the company are short sold. Based on an average daily volume of 81,300 shares, the days-to-cover ratio is presently 1.6 days.

NeuroOne Medical Technologies Price Performance

Shares of NASDAQ NMTC traded up $0.12 during mid-day trading on Tuesday, hitting $0.93. The company had a trading volume of 66,401 shares, compared to its average volume of 136,112. NeuroOne Medical Technologies has a 12 month low of $0.60 and a 12 month high of $2.00. The stock has a market cap of $25.89 million, a price-to-earnings ratio of -1.55 and a beta of 0.70. The firm’s 50 day simple moving average is $0.81 and its two-hundred day simple moving average is $0.97.

NeuroOne Medical Technologies (NASDAQ:NMTC) last issued its earnings results on Wednesday, August 14th. The company reported ($0.10) earnings per share for the quarter. NeuroOne Medical Technologies had a negative return on equity of 276.12% and a negative net margin of 308.51%. The company had revenue of $0.83 million during the quarter.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.